chemokin
produc
infect
inflamm
activ
chemokin
receptor
import
regul
lymphocyt
traffick
activ
goal
studi
assess
contribut
pathogenesi
experiment
septic
shock
mice
method
septic
shock
induc
cecal
ligat
punctur
clp
mice
resuscit
lactat
ringer
solut
case
broad
spectrum
antibiot
primaxin
studi
perform
knockout
mice
mice
treat
immunoglobulin
g
igg
endpoint
includ
leukocyt
traffick
activ
core
bodi
temperatur
plasma
cytokin
concentr
bacteri
clearanc
surviv
result
present
high
concentr
plasma
periton
caviti
clpinduc
septic
shock
surviv
significantli
improv
knockout
mice
mice
treat
igg
compar
control
mice
mice
treat
igg
show
attenu
hypothermia
lower
concentr
macrophag
inhibitori
plasma
lessen
natur
killer
nk
cell
activ
compar
control
mice
compar
control
mice
bacteri
burden
blood
lung
lower
mice
mice
treat
igg
treatment
mice
igg
plu
fluid
primaxin
hour
clp
significantli
improv
surviv
compar
mice
treat
nonspecif
igg
condit
conclus
play
role
pathogenesi
clpinduc
septic
shock
could
serv
therapeut
target
acut
phase
septic
shock
cxc
chemokin
also
known
interferoninduc
protein
produc
period
infect
inflamm
respons
type
type
ii
interferon
ifn
respect
activ
gprotein
coupl
chemokin
receptor
import
regul
natur
killer
nk
natur
killer
nkt
helper
th
lymphocyt
traffick
respons
viral
infect
autoimmun
diseas
allotransplant
cancer
recent
role
activ
pathogenesi
sever
sepsi
propos
compar
wildtyp
mice
mice
show
less
system
cytokin
product
attenu
physiolog
dysfunct
improv
surviv
sever
sepsi
caus
cecal
ligat
punctur
clp
larg
number
nk
cell
migrat
spleen
blood
periton
caviti
clpinduc
sepsi
phenomenon
ablat
mice
well
mice
treat
neutral
antibodi
thu
traffick
nk
cell
site
infect
clp
parallel
develop
system
inflamm
mortal
phenomena
ablat
defici
blockad
rais
content
improv
outcom
observ
septic
mice
defici
blockad
due
attenu
traffick
activ
innat
lymphocyt
popul
howev
research
need
determin
mechan
activ
facilit
pathogenesi
septic
shock
high
concentr
present
periton
lavag
fluid
plasma
clpinduc
septic
shock
increas
concentr
parallel
traffick
nk
cell
inflam
infect
periton
caviti
furthermor
high
concentr
correl
develop
physiolog
dysfunct
death
clp
model
sepsi
clinic
studi
plasma
concentr
markedli
elev
septic
patient
plasma
concentr
correl
sever
sepsi
human
punyadeera
et
al
report
elev
plasma
concentr
predict
transit
sepsi
septic
shock
critic
ill
adult
studi
elev
plasma
concentr
shown
reliabl
indic
sepsi
neonat
infant
howev
function
import
pathogenesi
sever
sepsi
ascertain
present
studi
effect
defici
blockad
pathogenesi
clpinduc
septic
shock
investig
surviv
core
bodi
temperatur
bacteri
clearanc
system
cytokin
product
well
lymphocyt
traffick
activ
evalu
mice
mice
treat
neutral
antibodi
blockad
initi
prior
onset
sepsi
latter
studi
goal
determin
whether
blockad
might
serv
therapeut
target
experiment
septic
shock
femal
male
j
wildtyp
mice
homozyg
mice
j
purchas
jackson
laboratori
bar
harbor
usa
mice
genotyp
facil
assur
authent
studi
approv
institut
anim
care
use
committe
univers
texa
medic
branch
vanderbilt
univers
medic
center
compli
nation
institut
health
guid
care
use
experiment
anim
conform
intern
recogn
guidelin
ethic
treatment
anim
clp
perform
previous
describ
briefli
mice
anesthet
isofluran
oxygen
shave
asept
prepar
surgic
site
midlin
incis
made
abdomin
wall
cecum
identifi
ligat
silk
sutur
cm
tip
depend
desir
sever
model
doubl
punctur
cecal
wall
perform
needl
incis
close
prolen
sutur
mice
resuscit
intraperiton
inject
ml
lactat
ringer
lr
solut
without
primaxin
mgkg
merck
co
whitehous
station
nj
usa
immedi
clp
primaxin
formul
imipenem
potent
broadspectrum
thienamycin
antibiot
cilastatin
sodium
inhibitor
renal
dipeptidas
dehydropeptidas
mice
receiv
buprenorphen
mgkg
subcutan
minut
prior
clp
twice
daili
thereaft
analgesia
mice
receiv
intraperiton
inject
polyclon
igg
nonspecif
igg
r
system
minneapoli
mn
usa
hour
clp
mice
resuscit
lactat
ringer
lr
solut
contain
primaxin
immedi
clp
subset
mice
monitor
surviv
addit
mice
rectal
temperatur
measur
sampl
harvest
measur
tissu
blood
bacteri
burden
cytokin
concentr
mice
underw
clp
receiv
intraven
treatment
polyclon
igg
nonspecif
igg
ml
lr
hour
clp
time
igg
treatment
mice
also
receiv
intraperiton
inject
lr
plu
primaxin
antibodi
given
intraven
posttreat
experi
speed
system
dissemin
mice
monitor
surviv
day
clp
mice
underw
clp
treat
intraven
iv
recombin
mous
r
system
ug
mous
vehicl
hour
clp
mice
monitor
surviv
rectal
temperatur
measur
indic
time
point
mice
receiv
intraperiton
resuscit
lr
immedi
clp
splenic
intraperiton
leukocyt
harvest
previous
describ
measur
nk
cell
number
made
hour
clp
mice
receiv
antibiot
treatment
previou
studi
show
signific
nk
cell
migrat
periton
caviti
hour
clp
briefli
spleen
harvest
place
dish
contain
media
fetal
bovin
serum
mash
plunger
syring
splenocyt
suspens
pass
nylon
mesh
erythrocyt
lyse
erythrocyt
lysi
kit
r
system
isol
splenocyt
resuspend
cellsml
pb
intraperiton
leukocyt
harvest
lavag
ml
pb
wash
count
cell
resuspend
pb
cellsml
cell
viabil
greater
case
determin
trypan
blue
exclus
isol
leukocyt
tube
place
polystyren
tube
incub
antimous
ebiosci
san
diego
ca
usa
block
nonspecif
fc
receptormedi
antibodi
bind
fluorochromeconjug
antibodi
isotyp
control
gtube
ad
incub
minut
wash
ml
cold
pb
cell
fix
paraformaldehyd
antibodi
use
analys
includ
ebiosci
well
appropri
isotyp
control
antibodi
sampl
analyz
accuri
flow
cytomet
bd
bioscienc
data
analyz
use
accuri
softwar
heparin
blood
obtain
carotid
lacer
plasma
harvest
follow
centrifug
g
minut
periton
caviti
lavag
ml
steril
pb
urea
use
standard
dilut
periton
lavag
sampl
urea
readili
diffus
freeli
throughout
tissu
fluid
compart
urea
concentr
plasma
periton
lavag
sampl
known
dilut
initi
volum
periton
fluid
obtain
calcul
previous
describ
urea
content
periton
lavag
plasma
sampl
determin
use
istat
cartridg
abbott
point
care
princeton
nj
usa
macrophag
inhibitori
concentr
measur
use
elisa
accord
manufactur
protocol
ebiosci
cytokin
concentr
determin
measur
optic
densiti
nm
use
microtit
plate
reader
dynatech
laboratori
chantilli
va
usa
previou
studi
laboratori
other
show
magnitud
system
product
clpinduc
sepsi
parallel
sever
physiolog
dysfunct
mortal
thu
cytokin
use
marker
system
inflamm
bodi
temperatur
measur
insert
lubric
rectal
temperatur
probe
prior
variou
time
clp
previou
studi
show
magnitud
hypothermia
correl
mortal
clp
model
thu
rectal
temperatur
use
marker
physiolog
dysfunct
model
arteri
blood
ga
analysi
perform
heparin
blood
use
istat
cartridg
abbott
diagnost
bacteri
count
perform
blood
periton
lavag
fluid
lung
homogen
sampl
blood
periton
lavag
fluid
obtain
describ
lung
tissu
harvest
asept
condit
weigh
homogen
steril
pb
achiev
final
concentr
mg
tissu
per
ml
salin
sampl
serial
dilut
steril
salin
plate
tryptic
soy
agar
plate
incub
hour
coloni
count
perform
direct
visual
data
analyz
use
graphpad
prism
softwar
graphpad
softwar
san
diego
ca
usa
data
multipl
group
experi
analyz
use
oneway
analysi
varianc
anova
follow
post
hoc
tukey
multicomparison
test
comparison
data
experi
use
two
group
subject
achiev
use
unpair
ttest
measur
bacteri
colonyform
unit
cfu
group
compar
use
nonparametr
kruskalw
test
follow
post
hoc
dunn
test
surviv
data
analyz
use
log
rank
test
valu
p
consid
statist
signific
experi
valu
present
mean
standard
error
mean
sem
except
bacteri
count
median
valu
design
concentr
increas
plasma
periton
caviti
within
hour
clp
remain
elev
hour
highest
concentr
measur
hour
clp
figur
concentr
periton
lavag
significantli
higher
plasma
hour
clp
detect
plasma
periton
lavag
fluid
knockout
mice
data
shown
effect
defici
surviv
rectal
temperatur
plasma
cytokin
concentr
clpinduc
sepsi
surviv
measur
controland
mice
figur
absenc
antibiot
treatment
knockout
mice
show
significantli
higher
surviv
rate
compar
wildtyp
mice
versu
likewis
mice
resuscit
fluid
antibiot
time
clp
show
significantli
higher
surviv
rate
compar
wildtyp
mice
versu
although
surviv
prolong
mice
receiv
antibiot
overal
mortal
rate
similar
without
antibiot
treatment
hypothermia
serv
reliabl
indic
physiolog
integr
surviv
mice
clpinduc
sepsi
studi
undertaken
assess
rectal
temperatur
wildtyp
mice
clpinduc
sepsi
mice
receiv
primaxin
temperatur
measur
hour
clp
wherea
temperatur
measur
hour
clp
mice
receiv
primaxin
part
resuscit
protocol
figur
time
point
chosen
due
effect
antibiot
treatment
time
initi
mortal
shown
figur
specif
initi
mortal
observ
hour
mice
receiv
antibiot
wherea
antibiot
treatment
prolong
initi
mortal
hour
clp
thu
measur
made
time
mortal
onset
respect
group
mice
receiv
primaxin
treatment
rectal
temperatur
significantli
decreas
wildtyp
mice
compar
nonsept
control
rectal
temperatur
significantli
higher
mice
compar
wildtyp
mice
figur
wildtyp
mice
treat
primaxin
exhibit
significantli
decreas
rectal
temperatur
hour
clp
compar
nonsept
control
rectal
temperatur
significantli
higher
mice
compar
wildtyp
mice
figur
plasma
concentr
also
measur
hour
clp
mice
treat
without
primaxin
respect
figur
mice
receiv
treatment
primaxin
plasma
concentr
significantli
lower
mice
compar
wildtyp
mice
mice
receiv
primaxin
treatment
plasma
concentr
lower
mice
compar
wildtyp
mice
bacteri
count
measur
control
mice
treat
without
primaxin
figur
treatment
primaxin
significantli
decreas
bacteri
count
periton
caviti
blood
lung
greater
two
order
magnitud
compar
tissu
mice
receiv
primaxin
treatment
figur
signific
differ
intraperiton
bacteri
count
observ
compar
wildtyp
mice
regardless
whether
primaxin
given
figur
bacteri
count
blood
lung
significantli
lower
mice
wildtyp
mice
primaxin
given
howev
primaxintr
mice
differ
bacteri
burden
observ
blood
lung
compar
wildtyp
mice
figur
studi
undertaken
assess
lymphocyt
traffick
wildtyp
mice
clp
studi
perform
absenc
antibiot
treatment
natur
killer
nk
cell
subdivid
immatur
proinflammatori
ii
cytotox
iii
subset
base
express
figur
upper
panel
figur
show
gate
strategi
use
identifi
nk
cell
subset
total
nk
cell
identifi
lymphocyt
figur
nk
cell
subset
identifi
proinflammatori
cytotox
base
express
describ
signific
declin
total
proinflammatori
cytotox
nk
cell
observ
spleen
hour
clp
correspond
increas
intraperiton
number
nk
cell
subset
time
period
figur
number
immatur
nk
cell
spleen
periton
lavag
chang
first
hour
clp
data
shown
signific
differ
splenic
intraperiton
nk
cell
number
note
compar
wildtyp
mice
figur
number
nkt
cell
spleen
periton
lavag
chang
hour
clp
either
group
data
shown
studi
undertaken
assess
earli
activ
intraperiton
lymphocyt
use
biomark
figur
intraperiton
nk
nkt
lymphocyt
wildtyp
mice
show
evid
activ
clp
indic
significantli
increas
percentag
cell
increas
mean
fluoresc
intens
mfi
figur
hour
postclp
percentag
nk
cell
mfi
nk
cell
significantli
lower
mice
compar
wildtyp
mice
nkt
cell
percentag
cell
mfi
significantli
differ
compar
lymphocyt
wildtyp
mice
figur
effect
blockad
surviv
core
bodi
temperatur
plasma
cytokin
concentr
bacteri
burden
clpinduc
sepsi
studi
undertaken
determin
whether
blockad
alter
surviv
clpinduc
sepsi
figur
wildtyp
mice
treat
igg
nonspecif
igg
hour
prior
clp
mice
resuscit
lr
primaxin
time
clp
surviv
significantli
improv
mice
treat
igg
compar
mice
treat
nonspecif
igg
versu
figur
see
figur
previou
page
figur
effect
cxc
chemokin
defici
core
bodi
temperatur
plasma
cytokin
cecal
ligat
punctur
clp
induc
sepsi
rectal
temperatur
plasma
macrophag
inhibitori
concentr
measur
mice
treat
without
primaxin
clp
n
mice
per
group
p
compar
control
p
compar
wildtyp
mice
wt
wildtyp
measur
made
onset
mortal
model
hour
postclp
mice
receiv
primaxin
hour
postclp
mice
receiv
antibiot
studi
rectal
temperatur
plasma
concentr
measur
wildtyp
mice
treat
igg
nonspecif
igg
figur
mice
resuscit
lr
plu
primaxin
clp
induc
signific
decreas
temperatur
wildtyp
mice
treat
nonspecif
igg
compar
nonsept
control
rectal
temperatur
significantli
decreas
mice
treat
igg
compar
nonsept
control
significantli
higher
mice
treat
nonspecif
igg
figur
examin
plasma
cytokin
show
concentr
significantli
lower
igg
group
compar
nonspecif
igg
group
figur
bacteri
count
measur
mice
treat
without
primaxin
figur
bacteri
count
periton
lavag
fluid
blood
lung
significantli
differ
mice
treat
nonspecif
igg
igg
regardless
whether
mice
treat
primaxin
figur
bacteri
count
measur
site
significantli
lower
mice
treat
primaxin
compar
receiv
primaxin
treatment
figur
effect
igg
treatment
surviv
administ
onset
sepsi
studi
undertaken
assess
whether
initi
blockad
onset
sepsi
would
improv
surviv
initi
studi
undertaken
character
progress
sepsi
model
determin
whether
evid
sepsi
present
time
igg
treatment
figur
rectal
temperatur
measur
indic
time
point
show
signific
declin
hour
clp
declin
hour
clp
compar
nonsept
hour
mice
figur
assess
acidbas
balanc
hour
clp
show
metabol
acidosi
compar
sham
mice
character
signific
decreas
blood
ph
bicarbon
concentr
figur
p
co
also
significantli
lower
septic
mice
compar
sham
control
reflect
respiratori
compens
emerg
metabol
acidosi
figur
plasma
concentr
significantli
increas
hour
clp
mice
also
bacterem
time
point
indic
posit
blood
cultur
mice
figur
mice
treat
igg
nonspecif
igg
combin
fluid
primaxin
hour
clp
procedur
figur
surviv
significantli
improv
wildtyp
mice
treat
igg
hour
versu
hour
clp
versu
compar
mice
treat
nonspecif
igg
figur
present
studi
show
defici
blockad
confer
protect
clpinduc
septic
shock
mice
regardless
whether
antibiot
given
sepsisinduc
hypothermia
system
cytokin
product
attenu
surviv
rate
higher
mice
mice
treat
neutral
antibodi
compar
control
mice
collect
observ
support
content
play
function
role
facilit
inflamm
physiolog
clpinduc
acut
septic
shock
addit
blockad
could
serv
therapeut
target
acut
septic
shock
treatment
igg
antibiot
effect
improv
surviv
administ
hour
onset
sepsi
improv
surviv
observ
mice
treat
igg
hour
clp
particularli
compel
mice
show
clinic
sign
sepsi
hypothermia
metabol
acidosi
system
inflamm
bacteremia
time
treatment
shown
serv
use
biomark
human
sepsi
sever
studi
report
increas
concentr
plasma
septic
human
adult
infant
neonat
punyadeera
colleagu
show
high
plasma
concentr
associ
transit
sepsi
septic
shock
critic
ill
adult
patient
elev
plasma
concentr
also
shown
reliabl
indic
sepsi
neonat
infant
howev
function
import
facilit
pathogenesi
sever
bacteri
sepsi
directli
examin
yet
prior
studi
shown
contribut
acut
organ
injuri
physiolog
dysfunct
acut
inflammatori
syndrom
ichikawa
colleagu
show
mice
lack
resist
acut
lung
injuri
caus
acid
aspir
influenza
viru
infect
neutral
effect
attenu
nk
cellmedi
hepatocellular
injuri
fulmin
dengu
viru
infect
role
pathogenesi
cerebr
malaria
also
describ
see
figur
previou
page
figur
effect
cxc
chemokin
defici
bacteri
burden
cecal
ligat
punctur
clp
induc
sepsi
bacteri
coloni
form
unit
cfu
measur
mice
treat
without
primaxin
clp
n
mice
per
group
p
compar
wildtyp
p
compar
mice
receiv
primaxin
treatment
measur
made
onset
mortal
model
hour
postclp
mice
receiv
primaxin
hour
postclp
mice
receiv
antibiot
studi
indirectli
support
role
pathogenesi
septic
shock
seyoum
et
al
report
virul
strain
pneumonia
induc
high
express
mice
exhibit
attenu
pulmonari
inflamm
improv
outcom
sepsi
caus
streptococc
pneumonia
studi
martin
colleagu
show
virul
strain
methicillinresist
staphylococu
aureu
mrsa
induc
high
concentr
lung
intrapulmonari
challeng
neutral
decreas
intrapulmonari
inflamm
present
studi
show
mice
resist
clpinduc
septic
shock
directli
support
causeandeffect
relationship
pathogenesi
sepsi
product
larg
regul
activ
type
type
ii
ifn
receptor
respect
transcript
factor
import
mediat
ifninduc
gene
transcript
play
central
role
regul
express
previou
studi
laboratori
show
mice
resist
clpinduc
septic
shock
knockout
mice
exhibit
improv
surviv
attenu
system
inflamm
diminish
product
clpinduc
sepsi
addit
studi
decreas
system
inflamm
improv
surviv
demonstr
type
ifn
receptorand
mice
fulmin
clpinduc
periton
endotoxininduc
shock
respect
dejag
et
al
report
blockad
type
ifn
signal
protect
model
endotoxin
clpinduc
sever
sepsi
studi
lachanc
colleagu
show
mice
resist
septic
shock
caus
virul
strain
streptococcu
sui
find
consist
previou
studi
demonstr
attenu
hyperinflamm
improv
surviv
mice
model
clpand
endotoxininduc
shock
taken
togeth
prior
find
result
present
studi
support
role
pathogenesi
septic
shock
mediat
hyperinflamm
shock
system
bacteri
infect
like
well
play
benefici
role
contain
local
less
sever
system
infect
kellyscumpia
colleagu
report
type
ifn
receptordefici
mice
increas
suscept
lower
sever
clpinduc
sepsi
control
mice
show
mortal
rate
less
heighten
suscept
associ
impair
bacteri
clearanc
report
vulner
revers
treatment
conclud
import
regul
antimicrobi
function
lowsever
clpinduc
sepsi
adult
mice
reim
et
al
also
report
ifninduc
respons
includ
product
benefici
facilit
bacteri
clearanc
mechan
lowersever
model
clpinduc
sepsi
studi
cuenca
et
al
show
import
neutrophil
macrophag
recruit
neonat
sepsi
studi
blockad
decreas
myeloid
cell
recruit
site
infect
decreas
bacteri
clearanc
increas
mortal
likewis
neonat
mice
show
decreas
number
neutrophil
macrophag
site
infect
increas
mortal
compar
wildtyp
control
investig
postul
regul
benefici
myeloid
cell
recruit
bacteri
sepsi
neonat
mice
interestingli
significantli
decreas
bacteri
count
observ
blood
lung
periton
caviti
knockout
mice
studi
howev
differ
bacteri
burden
observ
site
test
mice
treat
find
indic
could
small
inhibitori
effect
bacteri
clearanc
sever
sepsi
toto
combin
find
indic
product
benefici
deleteri
depend
sever
sepsi
mechan
facilit
system
inflamm
physiolog
dysfunct
sever
sepsi
remain
fulli
ascertain
activ
chemokin
receptor
import
regul
lymphocyt
traffick
varieti
diseas
character
infect
inflamm
express
primarili
nk
nkt
lymphocyt
implic
pathogenesi
septic
shock
previou
studi
laboratori
other
demonstr
nk
cell
contribut
system
inflamm
physiolog
dysfunct
sepsi
polytrauma
hu
colleagu
report
nkt
cell
play
function
role
pathogenesi
clpinduc
septic
shock
see
figur
previou
page
figur
natur
killer
cell
traffick
cecal
ligat
punctur
clp
induc
sepsi
wildtyp
cxc
chemokin
defici
mice
splenocyt
intraperiton
leukocyt
harvest
prior
hour
clp
natur
killer
nk
cell
identifi
use
flow
cytometri
lymphocyt
character
base
express
dn
doubl
neg
nk
cell
immatur
nk
cell
ii
proinflammatori
nk
cell
iii
cytotox
nk
cell
n
mice
per
group
p
compar
clp
investig
shown
nkt
cell
facilit
system
inflamm
lethal
challeng
lipopolysaccharid
lp
evid
indic
nk
cell
migrat
inflam
periton
caviti
blood
spleen
earli
cours
clpinduc
sepsi
addit
nk
cell
traffick
parallel
develop
physiolog
dysfunct
system
inflamm
experiment
septic
shock
present
studi
observ
traffick
nk
cell
spleen
periton
caviti
within
hour
clp
extend
previou
find
show
migrat
proinflammatori
cytotox
nk
cell
subset
yet
differ
nk
cell
traffick
observ
compar
wildtyp
mice
find
indic
alon
respons
nk
cell
traffick
clpinduc
sepsi
surpris
given
redund
ligand
previou
studi
show
high
level
ligand
produc
clp
concentr
gradient
exist
concentr
cytokin
higher
periton
caviti
plasma
thu
like
also
contribut
nk
cell
traffick
serv
import
nk
cell
chemoattract
absenc
studi
requir
fulli
defin
chemokin
milieu
mediat
nk
cell
traffick
sepsi
although
nk
cell
traffick
appear
crucial
factor
facilit
develop
shock
clp
model
nk
cell
activ
may
play
role
nk
cell
activ
system
inflamm
attenu
mice
indic
lessen
express
earli
activ
marker
intraperiton
nk
cell
decreas
system
cytokin
product
rais
possibl
serv
activ
factor
nk
cell
independ
role
chemotact
agent
previou
studi
shown
facilit
system
inflamm
acut
inflammatori
syndrom
howev
work
need
determin
facilit
proinflammatori
function
innat
lymphocyt
sever
sepsi
appear
potenti
serv
therapeut
target
acut
septic
shock
present
studi
blockad
combin
antibiot
treatment
hour
clp
effect
improv
surviv
compar
mice
treat
nonspecif
igg
antibiot
assess
indic
mice
show
sign
sepsi
hour
clp
indic
presenc
hypothermia
metabol
acidosi
bacteremia
work
need
fulli
defin
potenti
applic
blockad
therapeut
agent
acut
phase
septic
shock
treatment
igg
molecul
use
studi
attract
approach
alter
host
immun
respons
numer
diseas
immunolog
inflammatori
etiolog
base
current
observ
immunoglobulinbas
strategi
appear
repres
attract
strategi
block
set
sever
sepsi
howev
potenti
drawback
immunoglobulinbas
treatment
approach
import
persist
immunoglobulin
circul
system
administr
longliv
blockad
function
could
deleteri
mount
effect
downstream
antimicrobi
respons
patient
sepsi
demonstr
studi
kellyscumpia
colleagu
altern
approach
use
shortact
small
molecular
weight
inhibitor
block
receptor
potent
select
noncompetit
inhibitor
wide
test
human
undergo
hepat
metabol
exhibit
linear
pharmacokinet
first
day
administr
halflif
hour
thu
shortact
inhibitor
axi
could
serv
attract
agent
appli
acut
phase
sepsi
report
show
defici
blockad
improv
surviv
decreas
physiolog
dysfunct
attenu
system
cytokin
product
mice
septic
shock
addit
benefit
lung
bacteria
bacteria
cfuml
homogen
figur
see
legend
next
page
see
figur
previou
page
figur
effect
cxc
chemokin
blockad
bacteri
burden
cecal
ligat
punctur
clp
induc
sepsi
plasma
tissu
bacteri
count
measur
mice
treat
without
primaxin
clp
mice
treat
nonspecif
igg
igg
ug
intraperiton
ip
igg
ug
ip
hour
prior
clp
mice
receiv
intraperiton
resuscit
ml
lactat
ringer
solut
without
primaxin
mgkg
time
clp
n
mice
per
group
p
compar
primaxin
group
measur
made
hour
clp
plasma
bicarbon
figur
progress
sepsi
cecal
ligat
punctur
clp
model
mice
underw
sham
clp
procedur
rectal
temperatur
measur
indic
time
point
hour
clp
blood
harvest
measur
plasma
cytokin
acidbas
balanc
bacteri
burden
n
mice
per
group
p
compar
hour
clp
control
sham
macrophag
inhibitori
blockad
evid
igg
administ
hour
initi
sepsi
current
find
suggest
may
contribut
activ
innat
lymphocyt
popul
particularli
nk
cell
acut
septic
shock
research
need
fulli
defin
mechan
facilit
pathogenesi
septic
shock
defin
potenti
blockad
therapeut
intervent
high
level
produc
experiment
clinic
sepsi
defici
blockad
attenu
system
cytokin
product
lessen
physiolog
dysfunct
improv
surviv
experiment
septic
shock
contribut
activ
nk
cell
acut
phase
sepsi
act
alon
facilit
nk
cell
traffick
could
serv
therapeut
target
acut
phase
sepsi
abbrevi
cd
cluster
differenti
cfu
colonyform
unit
clp
cecal
ligat
punctur
cxc
chemokin
cxc
chemokin
cxc
chemokin
receptor
elisa
enzymelink
immunosorb
assay
ifn
interferon
igg
immunoglobulin
g
interferoninduc
protein
lr
lactat
ringer
solut
mfi
mean
fluoresc
intens
macrophag
inhibitori
nk
natur
killer
nkt
natur
killer
pb
phosphatebuff
salin
iv
intraven
author
declar
compet
interest
author
contribut
dh
design
perform
surviv
studi
cytokin
bacteri
burden
temperatur
measur
contribut
manuscript
prepar
design
perform
surviv
studi
cytokin
bacteri
burden
temperatur
measur
flow
cytometri
studi
contribut
manuscript
prepar
jb
perform
cytokin
measur
contribut
manuscript
prepar
ttk
contribut
experiment
design
data
interpret
manuscript
prepar
yg
perform
flow
cytometri
experi
contribut
manuscript
prepar
es
oversaw
aspect
studi
contribut
studi
design
data
interpret
manuscript
prepar
author
read
approv
manuscript
